Welcome to the future of Innovative Drug R&D in RussiaThe necessity for Russia to further develop its innovative drug R&D cannot be overstated. According to governmental strategy for the pharmaceutical industry up to 2020 (Pharma'2020), Russian innovative drugs should make up at least half of all available products in the Russian pharmaceutical market. To achieve such a result, it is vital to focus on stimulating the development and production of innovative drugs in Russia. Register by 17th SEPTEMBER and SAVE £200! SPEAKERS CONFIRMED TO DATE INCLUDE:
and many others...
|
Speakers of INNOVATIVE DRUGS R&D IN RUSSIA forum:
|
WHAT'S ON OFFER? Forum's Hihglights include:
This session will evaluate the prospects for the development of the innovative drugs market in Russia, analysing the results of recent consultation on legislation between representatives of regulatory authorities and from the industry itself, as well as offering an overview of current and planned projects. which will look at the prospects for the creation of a market for innovative and bio-technological drugs in Russia AND THEIR ROLE IN THE DEVELOPMENT OF THE RUSSIAN R&D SECTOR, which will analyse the opportunities and limitations for international players carrying out R&D in Russia During the discussion, representatives from leading VC and PE funds, pharmaceutical companies and leading financial consultants will talk what the realistic opportunities and mechanisms for financing are currently available for the development of innovative medical products in Russia The session will present examples of international best practice in creating and implementing successful biopharmaceutical cluster projects and will discuss what prospects exist for the creation and development of a modern innovation ecosystem in Russia a Two sessions devoted to discussing the regulation of the sector and practical aspects of conducting clinical research in Russia AFFECTING THE R&D SECTOR IN RUSSIA AND THE ESTABLISHMENT OF A REGULATORY FRAMEWORK FOR INNOVATIVE TECHNOLOGIES IN THE RUSSIAN PHARMACEUTICAL INDUSTRY. A discussion of the key challenges facing drug development companies in the sphere of observing and protecting intellectual property rights "HUMAN RESOURCES ARE ALL-IMPORTANT: HOW CAN THE SHORTAGE OF HIGHLY QUALIFIED PROFESSIONALS BE OVERCOME?" This discussion will examine a number of important questions surrounding one of the pressing problems hindering the development of innovative drugs in Russia - the lack of qualified staff Here is why this is the ONLY event in which to invest your time and money:
This forum will discuss the optimal strategies for success in the research, development and production of innovative drugs in Russia, with practical case studies from both Russian and international companies. To learn about sponsorship and exhibition opportunities, and to find out how you |
Premier Sponsor
Sponsors
Supporting organisations
Lead Information Partner
Lead Information Internet Partner
Official Analytical Information Partner
Information Partners
Share with:
